The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Under the terms of the agreement, SII has been granted a non-exclusive, worldwide licence in the field of Nipah virus vaccines, enabling the company to support the development, manufacture and potential future